Skip to main content
Erschienen in: Reactions Weekly 1/2020

01.07.2020 | Case report

Panitumumab

Acquired drug resistance, polyneuropathy and cutaneous toxicity: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Aguilar S, et al. RNF43- And NOTCH1-mutated chemotherapy and Anti-EGFR-refractory colorectal cancer: Should clonality guide target prioritization with investigational therapies?. JCO Precision Oncology 3: no pagination, Jan 2019. Available from: URL: http://doi.org/10.1200/PO.19.00182 Aguilar S, et al. RNF43- And NOTCH1-mutated chemotherapy and Anti-EGFR-refractory colorectal cancer: Should clonality guide target prioritization with investigational therapies?. JCO Precision Oncology 3: no pagination, Jan 2019. Available from: URL: http://​doi.​org/​10.​1200/​PO.​19.​00182
Metadaten
Titel
Panitumumab
Acquired drug resistance, polyneuropathy and cutaneous toxicity: case report
Publikationsdatum
01.07.2020
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2020
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-020-80943-z

Weitere Artikel der Ausgabe 1/2020

Reactions Weekly 1/2020 Zur Ausgabe

Case report

Rivoceranib

Case report

Sertraline

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Paclitaxel